2024    2023    2022    2021    2020    2019    2018    2017    2016   

2023

Workshop/conference papers

71 - 

Preliminary Findings of a Phase Ib/II Trial Indicate Manageable Safety and Promising Efficacy for Mosunetuzumab in Combination with Lenalidomide (M+Len) in Previously Untreated (1L) Follicular Lymphoma (FL)

Franck Morschhauser, Krish Patel, Sabela Bobillo, Raul Cordoba, Toby A Eyre, Mark Bishton, Roch Houot, Hui-Lai Zhang, Liqun Zou, Wendy Osborne et al.

65th ASH Annual Meeting, Dec 2023, San Diego, United States. pp.605,

DOI : https://doi.org/10.1182/blood-2023-174432

 

72 - 

Efficacy and Tolerance of Brexucabtagene Autoleucel in Adults with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia : A Graall Study from the Descar-T Registry

Florence Rabian, David Beauvais, Tony Marchand, Sabine Furst, Anne Huynh, Eolia Brissot, Sébastien Maury, Ludovic Gabellier, Patrice Chevallier, Michael Loschi et al.

65th ASH Annual Meeting, Dec 2023, San Diego, United States. pp.3498,

DOI : https://doi.org/10.1182/blood-2023-180575

 

73 - 

Glofitamab Monotherapy in Patients with Non-Hodgkin B-Cell Lymphoma after Failing CAR T-Cell Infusion: Primary Analysis of the Bicar Study, a Phase II Lysa Study

Pierre Sesques, Roch Houot, Yassine Al Tabaa, Fabien Le Bras, Loic Ysebaert, Fabrice Jardin, Sylvain Choquet, Jacques-Olivier Bay, François-Xavier Gros, Franck Morschhauser et al.

65th ASH Annual Meeting, Dec 2023, San Diego, United States. pp.893,

DOI : https://doi.org/10.1182/blood-2023-177703

 

74 - 

Hematopoietic Stem Cell Numbers Are Regulated at Both Systemic and Local Levels

Shoichiro Takeishi, Tony Marchand, Wade R. Koba, Daniel K. Borger, Chunliang Xu, Chandan Guha, Aviv Bergman, Paul S Frenette, Kira Gritsman, Ulrich Steidl et al.

65th ASH Annual Meeting, Dec 2023, San Diego, United States. pp.511-511,

DOI : https://doi.org/10.1182/blood-2023-174407

 

75 - 

The Role of BOB1 in Chronic Lung Allograft Dysfunction

N. Yeremenko, A. Foureau, N. Sailliet, E. Durand, C. Delaloy, A. Tissot, A. Tomilin, S. Brouard

Annual Meeting of the American-Society-of-Transplant-Surgeons (ASTS), Jun 2023, San Diego, United States.

 

76 - 

Tazemetostat in Combination with R-CHOP in Patients with High-Risk, Frontline Follicular Lymphoma (Epi-RCHOP): A Phase II Study from the Lysa

Loic Ysebaert, François Lemonnier, Gabriel Brisou, Olivier Casasnovas, Gian Matteo Pica, Emmanuel Bachy, Ludovic Fouillet, Julie Abraham, Stéphanie Guidez, Marc André et al.

65th ASH Annual Meeting, Dec 2023, San Diego, United States. pp.297,

DOI : https://doi.org/10.1182/blood-2023-185057

 

77 - 

Real-Word Experience of CAR T-Cells in Patients with Relapsed/Refractory Follicular Lymphoma : A Descart Registry Analysis from the Lysa

Loic Ysebaert, Roch Houot, René-Olivier Casasnovas, Sylvain Choquet, Fabrice Jardin, Michael Loschi, Gabriel Brisou, Catherine Thieblemont, Jacques-Olivier Bay, Cristina Castilla-Llorente et al.

65th ASH Annual Meeting, Dec 2023, San Diego, United States. pp.296,

DOI : https://doi.org/10.1182/blood-2023-184653

 

78 - 

Impact thérapeutique des cellules stromales mésenchymateuses adipocytaires sur les sous-populations myéloïdes dans des modèles murins de sclérodermie

F. Zimmermann, L. Morin, L. Marie, J. Gauthier, L. Séverine, E. Dessauge, T. Lejeune, C. Delaloy, Karin Tarte, Alain Lescoat et al.

86e CONGRÈS FRANÇAIS DE MÉDECINE INTERNE, Jul 2023, La Rochelle, France. pp.A90-A91,

DOI : https://doi.org/10.1016/j.revmed.2023.04.303